Cartesian Therapeutics Inc. (RNAC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
224,192,000
EV to revenue ratio (TTM)
104.51
EV to ebitda
1.766
Financial Performance
Revenue (TTM)
1,477,000
Gross profit (TTM)
-66,908,000
EBITDA
-96,051,000
Profitability
Operating margin (TTM)
-6,680.00%
Profit margin
0.00%
Return on assets (TTM)
-17.40%
Return on equity (TTM)
-7,029.00%
Per Share Metrics
Revenue per share (TTM)
0.06
EPS
-5.78
Diluted EPS (TTM)
-5.78
Book value
-4.17
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
25.06
PEG ratio
0
Price to sales ratio (TTM)
151.79
Price to book ratio (TTM)
31.26
Growth
Quarterly earnings growth (YoY)
-92.90%
Quarterly revenue growth (YoY)
-8.00%
Analyst Sentiment
Strong buy
1
Buy
7
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.619